Sei Investments CO Vanda Pharmaceuticals Inc. Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Sei Investments CO holds 518,851 shares of VNDA stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

518,851

Previous 371,785 39.56%

Holding current value

$2.73 Million

Previous $1.57 Million 35.97%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$3.47 - $4.61 $510,319 - $677,974	147,066 Added 39.56%	518,851 $2.13 Million
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $216,759 - $293,715	64,130 Added 20.84%	371,785 $1.57 Million
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $468,073 - $718,514	109,363 Added 55.15%	307,655 $1.33 Million
Q2 2023 Aug 11, 2023	BUY	$5.9 - $6.95 $46,020 - $54,210	7,800 Added 4.09%	198,292 $1.31 Million
Q1 2023 May 12, 2023	SELL	$6.18 - $7.99 $19,547 - $25,272	-3,163 Reduced 1.63%	190,492 $1.29 Million

Q4 2022 Feb 10, 2023	BUY	$6.87 - $10.96 $376,530 - $600,695	54,808 Added 39.47%	193,655 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $871,585 - $1.09 Million	92,329 Added 198.48%	138,847 $1.37 Million
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $716,497 - $911,206	-76,960 Reduced 62.33%	46,518 $507,000
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $37,224 - $56,832	-3,434 Reduced 2.71%	123,478 $1.4 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $1.02 Million - $1.37 Million	-64,858 Reduced 33.82%	126,912 $1.99 Million
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $132,746 - $183,942	-8,648 Reduced 4.31%	191,770 $3.29 Million
Q2 2021 Aug 06, 2021	BUY	$15.71 - $21.51 $606,783 - $830,802	38,624 Added 23.87%	200,418 $4.3 Million
Q1 2021 May 12, 2021	BUY	$13.42 - $20.28 $53,304 - $80,552	3,972 Added 2.52%	161,794 $2.39 Million
Q4 2020 Feb 08, 2021	BUY	$9.77 - $13.81 $194,510 - $274,943	19,909 Added 14.44%	157,822 $2.05 Million
Q3 2020 Dec 04, 2020	SELL	$9.32 - $12.02 $559 - $721	-60 Reduced 0.04%	137,913 $1.31 Million
Q3 2020 Nov 06, 2020	BUY	$9.32 - $12.02 $252,506 - $325,657	27,093 Added 24.43%	137,973 $1.31 Million
Q2 2020 Aug 17, 2020	SELL	$9.66 - $12.02 $816,521 - $1.02 Million	-84,526 Reduced 43.26%	110,880 $1.27 Million
Q2 2020 Aug 11, 2020	BUY	$9.66 - $12.02 $819,245 - $1.02 Million	84,808 Added 76.68%	195,406 $3.2 Million
Q1 2020 May 14, 2020	SELL	$7.5 - $16.8 $715,927 - $1.6 Million	-95,457 Reduced 46.33%	110,598 $1.15 Million
Q4 2019 Feb 06, 2020	BUY	$12.38 - $17.47 $135,325 - $190,964	10,931 Added 5.6%	206,055 $3.38 Million
Q3 2019 Nov 12, 2019	BUY	$12.27 - $15.79 $179,191 - $230,597	14,604 Added 8.09%	195,124 $2.59 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $115,356 - $162,637	8,628 Added 5.02%	180,520 $2.54 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $115,478 - $203,843	6,565 Added 3.97%	171,892 $3.16 Million
Q4 2018 Feb 13, 2019	BUY	$18.97 - $31.47 $590,555 - $979,692	31,131 Added 23.2%	165,327 $3.89 Million
Q3 2018 Nov 08, 2018	BUY	$18.25 - $23.0 $815,519 - $1.03 Million	44,686 Added 49.92%	134,196 $3.08 Million
Q2 2018 Aug 03, 2018	SELL	$13.95 - $19.15 $2.43 Million - $3.34 Million	-174,449 Reduced 66.09%	89,510 $1.71 Million
Q1 2018 May 11, 2018	SELL	$14.05 - $20.2 $184,462 - $265,205	-13,129 Reduced 4.74%	263,959 $4.45 Million
Q4 2017 Feb 08, 2018	BUY	$12.85 - $18.1 $121,008 - $170,447	9,417 Added 3.52%	277,088 $4.21 Million
Q3 2017 Nov 06, 2017	BUY	$15.4 - $18.85 $4.12 Million - $5.05 Million	267,671	267,671 $4.79 Million

Others Institutions Holding VNDA

# of Institutions

148

Shares Held

49.6M

Call Options Held

49.1K

Put Options Held

107K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $298M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Vanda Pharmaceuticals Inc. Transaction History